Correction to: Scientific Reports https://doi.org/10.1038/srep14421, published online 23 September 2015
This Article contains errors.
Figure S2 contains duplicated panels. In the original image, the panel for B16F10 in spleen is duplicated as the panel for pVector-B16F10 in spleen. This duplication is a result of errors in figure assembly.
The previous correction of this figure, published on 20 October 2017, also contains duplications introduced during the assembly of the revised figure: panel n.s. for spleen is duplicated as panel pFAB-b16F10 for spleen.
The corrected Figure S2, addressing both errors, appears below as Figure 1.
The pFAP-transfected tumor cell vaccine did not cause obvious pathologic changes in normal tissues. Paraformaldehyde fixed organs (heart, liver, spleen, lungs and kidneys) were processed for paraffin embedding and then stained by hematoxylin and eosin. Images shown are representatives from each group. Scale bars represent 100 μm.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, M., Xiang, R., Wen, Y. et al. Author Correction: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts. Sci Rep 10, 15609 (2020). https://doi.org/10.1038/s41598-020-72743-8
Published:
DOI: https://doi.org/10.1038/s41598-020-72743-8
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
